Oxford BioDynamicsLSE:OBD +11.11% Days Payable is 721.88 as of Sep. 2025, which is 47% above its 10-year median of 492.40. The stock has 4 warning signs investors should review. Among 190 Medical Diagnostics & Research companies, Oxford BioDynamics ranks better than 92.11% on this metric.
The historical rank and industry rank for Oxford BioDynamics's Days Payable or its related term are showing as below:
LSE:OBD'
s Days Payable Range Over the Past 10 Years
Min: 125.91 Med: 492.4 Max: 5950.46
Current: 692.84
During the past 13 years, Oxford BioDynamics's highest Days Payable was 5950.46. The lowest was 125.91. And the median was 492.40.
LSE:OBD's Days Payable is ranked better than 92.11% of 190
companies
in the Medical Diagnostics & Research industry
Industry Median: 67.275
vs LSE:OBD: 692.84
Oxford BioDynamics's Days Payable
declined
from Sep. 2024 (2,143.78) to Sep. 2025 (721.88).
It may suggest that Oxford BioDynamicsaccelerated paying its suppliers.
Oxford BioDynamics Days Payable Related Terms
Oxford BioDynamics Days Payable Historical Data
* Premium members only.
The historical data trend for Oxford BioDynamics's Days Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
LSE:OBD vs TMO, DHR, IDXX: Days Payable Comparison
For the Diagnostics & Research subindustry, Oxford BioDynamics's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Oxford BioDynamics Days Payable vs Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, Oxford BioDynamics's Days Payable distribution charts can be found below:
* The bar in red indicates where Oxford BioDynamics's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
Oxford BioDynamics's Days Payable for the fiscal year that ended in Sep. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Oxford BioDynamics (LSE:OBD) has a Days Payable of 721.88 as of Sep. 2025. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Oxford BioDynamics and its competitors. This is 47% above median its historical median of 492.40. Over the past decade, Oxford BioDynamics' Days Payable has ranged from 125.91 to 5,950.46. According to the industry distribution chart, Oxford BioDynamics ranks #15 out of 190 companies in the Medical Diagnostics & Research industry, placing it in the top 7.9%.
Is Oxford BioDynamics' Days Payable too high?
Oxford BioDynamics' current Days Payable of 721.88 is 47% above median its 10-year median of 492.40. Over the past 10 years, this metric has ranged from a low of 125.91 to a high of 5,950.46. The Medical Diagnostics & Research industry median Days Payable is 67.28. Oxford BioDynamics' value of 721.88 is 973% above this industry median. Based on the distribution chart, Oxford BioDynamics ranks #15 out of 190 companies in the Medical Diagnostics & Research industry, which is in the top quartile — a strong position relative to peers.
How does Oxford BioDynamics' Days Payable compare to TMO and DHR?
According to the Medical Diagnostics & Research industry distribution chart, Oxford BioDynamics ranks #15 out of 190 companies for Days Payable. This places Oxford BioDynamics in the top 8% of its industry — outperforming the majority of peers. The industry median Days Payable is 67.28. Oxford BioDynamics' value of 721.88 is 973% above this benchmark. Historically, Oxford BioDynamics' own Days Payable has ranged from 125.91 to 5,950.46 over the past decade. While the company's 10-year median is 492.40 vs. the industry median of 67.28, Oxford BioDynamics has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Medical Diagnostics & Research company?
The median Days Payable among Medical Diagnostics & Research companies is 67.28, based on 190 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Oxford BioDynamics's current Days Payable of 721.88 is 973% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Oxford BioDynamics and its competitors. For the Medical Diagnostics & Research industry, the median Days Payable is 67.28 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Oxford BioDynamics's current Days Payable is 721.88, which is 47% above median its own 10-year median of 492.40. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Oxford BioDynamics stock overvalued right now?
Based on GuruFocus' analysis, Oxford BioDynamics (LSE:OBD) is currently considered Possible Value Trap. The stock's GF Value™ is £0.02, compared to a current price of £0.00 — trading 92.5% below its estimated fair value. The current Days Payable is 721.88, which is 47% above median its 10-year median of 492.40 and 973% above the Medical Diagnostics & Research industry median of 67.28. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Oxford BioDynamics (LSE:OBD), the current Days Payable is 721.88 as of Sep. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Oxford BioDynamics PLC is a biotechnology company focused on advancing personalized healthcare through the development and commercialization of precision medicine tests for serious and impactful diseases. The company is engaged in the commercialisation of proprietary molecular diagnostics products and biomarker research and development. It has two commercially available products: the EpiSwitch PSE (EpiSwitch Prostate Cancer Detection Test) and EpiSwitch CiRT (Checkpoint Inhibitor Response Test) blood tests. The company generates revenue from the sales of proprietary products and biomarker research and development. Geographically, it generates the maximum revenue from the USA.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
LSE:OBD has been successfully added to your 